Sgltr-M Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Remogliflozin Etabonate (100mg) + Metformin (500mg)
Overview Sgltr-M Tablet
Sglt2-inhibitor M tablets combine medications to manage blood glucose. This medication, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It improves insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and duration; take it with or without food, consistently at the same time daily. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose and resume your regular schedule. Avoid doubling the dose; overdose can cause hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; monitor blood sugar levels closely. Common, generally transient side effects include nausea, indigestion, and abdominal discomfort. Consult your doctor if these persist. Inform your doctor of any kidney, liver, or heart conditions before use, and pregnant or breastfeeding individuals should seek medical advice. Kidney function tests will be performed prior to treatment initiation. Limit alcohol consumption as it may exacerbate side effects.
Uses of Sgltr-M Tablet
Managing Type 2 Diabetes
Major Benefits of Sgltr-M Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sgltr-M Tablets should be administered with a meal.
Common Side effects of Sgltr-M Tablet:
- Urinary tract infection
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Loss of appetite
- Hypoglycemia (low blood glucose level)
How to use Sgltr-M Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sgltr-M Tablet with a meal.
How Sgltr-M Tablet works:
Sglt2-M tablets contain a dual-action formula to manage diabetes. Remogliflozin etabonate, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, facilitates the excretion of excess glucose via the urine. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity. This combined mechanism effectively regulates blood glucose levels and treats diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Sglt2-M tablets.
PregnancyCONSULT YOUR DOCTOR
Using Sgltr-M Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Sgltr-M tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney disease should exercise caution when using Sgltr-M Tablets, as dose modification may be necessary. Consult your physician for guidance. The medication is contraindicated for individuals with moderate to severe kidney impairment.
LiverUNSAFE
Patients with liver impairment should not take Sgltr-M Tablets due to the potential for adverse effects. Medical advice is recommended.
What if you forget to take Sgltr-M Tablet :
Should you forget a Sgltr-M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Sgltr-M Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently